Second, TDF treatment has been reported to increase serum IFN-λ3 levels in patients with hepatitis B or HIV as well as IFN-λ3 secretion from cultured colon cancer cell lines,33 indicating a role for type III IFN. This evidence concerns the gene IFNL3 and malignant colon neoplasm.